论文部分内容阅读
目的:探讨三种方案治疗小儿轮状病毒肠炎的临床疗效及经济学效益。方法:采用回顾性调查方法,分别对常规治疗(A组)、利巴韦林(B组)、热毒宁注射液(C组)治疗小儿轮状病毒肠炎进行疗效评价,并进行成本-效果分析。结果:A、B、C组总有效率分别为65.71%8、1.08%9、3.75%(χ2=9.793,P<0.05),总成本分别为641.0、670.5、873.0元,成本-效果比分别为975.5、827.09、31.2,B、C组增量成本-效果比分别为191.9、816.9。结论:B方案治疗小儿轮状病毒肠炎较佳。
Objective: To investigate the clinical efficacy and economic benefit of three kinds of regimens in treating children with rotavirus enteritis. Methods: A retrospective survey was conducted to evaluate the efficacy of routine treatment (group A), ribavirin (group B) and Revedynin injection (group C) in treating children with rotavirus enteritis, and cost-effectiveness analysis. Results: The total effective rates in groups A, B and C were 65.71% 8,1.08% 9,3.75% (χ2 = 9.793, P <0.05) respectively. The total costs were 641.0,670.5 and 873.0 yuan respectively. The cost- 975.5,827.09,31.2, B, C incremental cost - effect ratio were 191.9,816.9. Conclusion: B treatment of children with rotavirus enteritis is better.